Original article SelectivevalidationoftheWHOBleedingScalein patients with chronic immune thrombocytopenia

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families.

  2011cited by this paper
• Fatigue in adult patients with primary immune thrombocytopenia

  2011cited by this paper
• Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study.

  2011cited by this paper
• EXTEND Study Update: Safety and Efficacy of Eltrombopag In Adults with Chronic Immune Thrombocytopenia (ITP) From June 2006 to February 2010

  2010cited by this paper
• International consensus report on the investigation and management of primary immune thrombocytopenia.

  2010cited by this paper
• Dose of prophylactic platelet transfusions and prevention of hemorrhage.

  2010cited by this paper
• A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia.

  2009cited by this paper
• Relationships among bleeding severity, health‐related quality of life, and platelet count in children with immune thrombocytopenic purpura

  2009cited by this paper
• Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.

  2009cited by this paper
• A clinical score predicting a brief and uneventful course of newly diagnosed idiopathic trombocytopenic purpura in children

  2007cited by this paper
• The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP

  2007cited by this paper
• The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia.

  2006cited by this paper
• Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial.

  2004cited by this paper
• Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies

  2003cited by this paper
• Immune thrombocytopenic purpura.

  2002cited by this paper
• Grading of hemorrhage in children with idiopathic thrombocytopenic purpura.

  2002cited by this paper
• Reporting results of cancer treatment

  1981cited by this paper
• Intraclass correlations: uses in assessing rater reliability.

  1979cited by this paper

• No citing papers are available for this paper.